Effects of neonatal amygdala lesions on [125I] neurotensin binding in specific brain areas of adult rat

European Journal of Neuroscience

Volumn 17, Issue 6, 2003, Pages 1319-1322

  Bouwmeester, Hans ^a   Snapper, Jolanda ^a   Ronken, Eric ^b   Kruse, Chris G ^b   Van Ree, Jan M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Animal model; Development; Dopamine; Schizophrenia

Indexed keywords

NEUROTENSIN; NEUROTENSIN RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; IN VITRO STUDY; MALE; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RECEPTOR DENSITY; SCHIZOPHRENIA;

AMYGDALA; ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BRAIN; HIPPOCAMPUS; IODINE RADIOISOTOPES; NEUROTENSIN; RATS; RATS, WISTAR; RECEPTORS, NEUROTENSIN; SCHIZOPHRENIA;

EID: 0037363633     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02606.x     Document Type: Article

References (27)

1. Azriel, Y. & Burcher, E. (2001) Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon. J. Pharmacol. Exp. Ther., 297, 1074-1081.
2. Betancur, C., Canton, M., Burgos, A., Labecuw, B., Gully, D., Rostene, W. & Pelaprat, D. (1998) Characterization of binding sites of a new neurotensin receptor antagonist, [31T]SR 142948A, in the rat brain. Eur. J. Pharmacol., 343, 67-77.
3. Binder, E.B., Kinkead, B., Owens, M.J. & Nemeroff, C.B. (2001a) Neurotensin and dopamine interactions. Pharmacol. Rev., 53, 453-486.
4. Binder, E.B., Kinkead, B., Owens, M.J. & Nemeroff, C.B. (2001b) The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biol. Psychiatry, 50, 856-872.
5. Boudin, H., Pelaprat, D., Rostene, W., Pickel, V.M. & Beaudet, A. (1998) Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra. J. Neurosci., 18, 8473-8484.
6. Daenen, E.W., Van der Heiden, J.A., Kruse, C.G., Wolterink, G. & Van Ree, J.M. (2001) Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus. Brain Res., 918, 153-165.
7. Daenen, E.W.P.M., Wolterink, G., Gerrits, D.A., Van Der Heiden, J.A., Kruse, C.G. & Van Ree, J.M. (1999) Amygdala or ventral hippocampal lesions at two early stages of life differentially affect prepulse inhibition of the acoustic startle response: an animal model of a neurodevelopmental disorder like schizophrenia. Eur. Neuropsychopharmacol., 10, S325.
8. Febvret, A., Berger, B., Gaspar, P. & Verney, C. (1991) Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices. Brain Res., 547, 3752.
9. Garver, D.L., Bissette, G., Yao, J.K. & Nemeroff, C.B. (1991) Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. Am. J. Psychiatry, 148, 484-488.
10. Gaspar, P., Berger, B. & Febvret, A. (1990) Neurotensin innervation of the human cerebral cortex: lack of colocalization with catecholamines. Brain Res., 530, 181-195.
11. Gruber, S.H., Nomikos, G.G. & Mathe, A.A. (2002) Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat. Neuropsychopharmacology, 26, 595-604.
12. Gully, D., Labeeuw, B., Boigegrain, R., Oury-Donat, F., Bachy, A., Poncelet, M., Steinberg, R., Suatid-Chagny, M.F., Santucci, V., Vita, N., Pecceu, 1.7., Labbe-Jullie, C., Kitabgi, P., Soubrie, P., Le Fur, G. & Maffirand, J.P. (1997) Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J. Pharmacol. Exp. Ther., 280, 802-812.
13. Hökfelt, T., Everitt, B.J., Theodorsson-Norheim, E. & Goldstein, M. (1984) Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J. Comp. Neurol., 222, 543-559.
14. Jentsch, J.D. & Roth, R.H. (1999) The neuropsychopharmacology of phencyclidine: from NMBA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 20, 201-225.
15. Kalivas, P.M., Burgess, S.K., Nemeroff, C.B. & Prange, A.J., Jr (1983) Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmentai area of the rat. Neuroscience, 8, 495-505.
16. Kasckow, J. & Nemeroff, C.B. (1991) The neurobiology of neurotensin: focus on neurotensin-dopamine interactions. Regul. Pept., 36, 153-164.
17. Kinkead, B., Binder, E.B. & Nemeroff, C.B. (1999) Does neurotensin mediate the effects of antipsychotic drugs? Biol. Psychiatry, 46 (340-35), 1.
18. Kinkead, B. & Nemeroff, C.B. (2002) Neurotensin: an endogenous antipsychotic? Curr. Opin. Pharmacol., 2, 99-103.
19. Napier, T.C., Gay, D.A., Hulebak, K.L. & Breese, G.R. (1985) Behavioral and biochemical assessment of time-related changes in globus pallidus and striatal dopamine induced by intranigrally administered neurotensin. Peptides, 6, 10571068.
20. Nemeroff, C.B. (1980) Neurotensin: perchance an endogenous neuroleptic? Biol. Psychiatry, 15, 283-302.
21. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotactic Coordinates. Orlando: Academic Press.
22. Sakamoto, N., Michel, I.P., Kiyama, H., Tohyama, M., Kopp, N. & Pearson, J. (1986) Neurotensin immunoreactivity in the human cingulate gyrus, hippocampal subiculum and mammillary bodies. Its potential role in memory processing. Brain Res., 375, 351-356.
23. Seutin, V., Massotte, L. & Dresse, A. (1989) Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology, 28, 949-954.
24. Shi, W.X. & Bunney, B.S. (1991) Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity. Brain Res., 543, 315-321.
25. Tyler-McMahon, M., Boules, M. & Richelson, E. (2000) Neurotensin: peptide for the next millennium. Regul. Pept., 93, 125-136.
26. Wolterink, Ci, Daenen, L.E., Dubbeldam, S., Gerrits, M.A., Van Rijn, R., Kruse, C.G., Van Der Heijden, J.A. & Van Ree, J.M. (2001) Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. Eur. Neuropsychopharmacol., 11, 51-59.
27. Zahm, S., Grosu, S., Williams, E.A., Qin, S. & Berod, A. (2001) Neurons of origin of the neurotensinergic plexus enmeshing the ventral tegmental area in rat: retrograde labeling and in situ hybridization combined. Neuroscience, 104, 841-851.